The purpose of this exploratory study was to investigate the impact of TNF blockade on IL-17 levels in target tissues by evaluating the effects of adalimumab treatment on IL-17A, IL-17F and their receptors in paired skin and synovial tissue biopsies of patients suffering from PsA with moderate psoriasis lesions. Here, IL17A is linked to psoriasis.